MedTrace Logo

Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy

NCT06248333 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-07-15

No results posted yet for this study

Summary

The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of subthalamic nucleus (STN) as adjunctive therapy for reducing the frequency of seizures in drug-resistant focal motor epilepsy.

Conditions

  • Epilepsy, Drug Resistant

Interventions

DEVICE

STN-DBS ON

Stimulation ON

DEVICE

STN-DBS OFF

Stimulation OFF

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Beijing Sanbo Brain Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Peking University

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Liankun Ren, MD · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-14
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248333 on ClinicalTrials.gov